Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-04

Clinical Trial Update: Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating subanesthetic IV ketamine for acute depression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Acute Depression | Phase 1 | Status: TERMINATED